Psychosis Clinical Trial
— CARMSOfficial title:
A Psychological Intervention for Suicide Applied to Patents With Psychosis: the CARMS Trial (Cognitive Approaches to Combatting Suicidality)
Verified date | May 2023 |
Source | University of Manchester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomised controlled trial which investigates the effectiveness of CARMS (Cognitive AppRoaches to coMbatting Suicidality) therapy in reducing suicidal thoughts and how well CARMS works in practice within the NHS. The trial will compare two groups of people with psychosis who are using NHS mental health services. One group will carry on with their usual treatment. The other group will be offered 24 weekly sessions of CARMS therapy, plus their usual treatment.
Status | Completed |
Enrollment | 329 |
Est. completion date | January 27, 2022 |
Est. primary completion date | January 27, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - ICD-10 diagnosis of psychosis (i.e. F20 - F29) - suicidal thoughts and/or acts in the past three months - in contact with mental health services and under the care of a mental health services clinical team (i.e., community or inpatient mental health care teams) with a care coordinator - aged 18 or over - English-speaking (hence, not needing an interpreter) - able to give informed consent as assessed by either a responsible clinician or by trial RAs following the British Psychological Society's guidelines on gaining informed consent (http://www.bps.org.uk/sites/default/files/documents/code_of_human_research_ethics.pdf ) Exclusion Criteria: - dementia, or an organic brain disorder - unable to complete assessments due to language barriers - currently taking part in a clinical trial. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Pennine Care NHS Foundation Trust | Ashton under Lyne | |
United Kingdom | Lancashire Care NHS Foundation Trust | Chorley | |
United Kingdom | Greater Manchester Mental Health NHS Trust | Manchester | |
United Kingdom | Northwest Boroughs Healthcare NHS Foundation Trust | Warrington |
Lead Sponsor | Collaborator |
---|---|
University of Manchester | Greater Manchester Mental Health NHS Foundation Trust, Lancaster University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change from Baseline Difficulties in Emotional Regulation Scale score at 6 and 12 months | The questionnaire measures emotional dysregulation | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Social Problem-Solving Inventory score at 6 and 12 months | The questionnaire measures individual's social problem-solving skills | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Social Support Appraisals Scale score at 6 and 12 months | The questionnaire measures individual's appraisals of social support | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Beck Hopelessness Scale score at 6 and 12 months | The questionnaire measures three aspects of hopelessness: feelings about the future, loss of motivation, and expectations | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Defeat and Entrapment scale scores at 6 and 12 months | The questionnaire measures how defeated and trapped individuals feel respectively | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Positive and Negative Syndrome Scale score at 6 and 12 months | Clinical interview to assess symptom severity of individual's experiencing Schizophrenia | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Psychotic Symptoms Ratings Scale (PSYRATS) score at 6 and 12 months | Clinical interview to assess symptoms of psychosis | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Personal and Social Performance Scale score at 6 and 12 months | Clinical interview to assess personal and social functioning in individual's experiencing Schizophrenia | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Calgary Depression Scale score at 6 and 12 months | Clinical interview to assess symptoms of depression in individual's experiencing Schizophrenia | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Frequency and Type of Substance Misuse as measured by the Timeline Follow Back at 6 and 12 months | Clinical interview to ascertain frequency and type of substance misuse over 3 months | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Drug use (self-reported) DAST score at 6 and 12 months | Measure which identifies drug 'abuse' | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Alcohol use (self-reported) AUDIT score at 6 and 12 months | Gold standard measure which identifies alcohol use | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Reasons for substance Use Scale - Alcohol and Drugs scores at 6 and 12 months | Questionnaire measure which identifies individual's reasons for using alcohol and drugs respectively | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline Sleep Condition Indicator score at 6 and 12 months | The questionnaire measures insomnia | Baseline, 6 month and 12 month follow up | |
Other | Current medication for mental health problems as prescribed at baseline assessment time point | Information regarding which anti-psychotic medication, if the medication is atypical, and the dosage will be collected from medical records | Baseline | |
Other | Change from Baseline Working Alliance Inventory - short form score at 6 and 12 months | The questionnaire measure the client-therapist therapeutic alliance from the participant's and the therapist's perspective | Baseline, 6 month and 12 month follow up | |
Other | Change from Baseline EQ-5D score at 12 months | The questionnaire measures health outcomes | Baseline and 12 month follow up | |
Other | Change from Baseline Client Service Use Receipt Inventory at 12 months | The questionnaire measures use of services | Baseline and 12 month follow up | |
Primary | Change from Baseline Adult Suicide Ideation Questionnaire score at 6 and 12 months | Suicidal ideation valid measure | Baseline, 6 month and 12 month follow up | |
Secondary | Change from Baseline Suicide Probability Scale score at 6 and 12 months | Suicide risk valid measure | Baseline, 6 month and 12 month follow up | |
Secondary | Change from Baseline Beck Scale for Suicidal ideation score at 6 and 12 months | Assess an individual's thoughts, attitudes and intentions regarding suicide | Baseline, 6 month and 12 month follow up | |
Secondary | Change from Baseline Frequency of suicidal thoughts, plans and acts at 6 and 12 months | Clinical interview to ascertain frequency of suicidal thoughts, plans and acts across six months | Baseline, 6 month and 12 month follow up | |
Secondary | Change from Baseline Frequency of Suicide Attempts at 6 and 12 months | Frequency of suicide attempts will be collected from medical records | Baseline, 6 month and 12 month follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04929938 -
Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients
|
N/A | |
Recruiting |
NCT05863572 -
Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
|
N/A | |
Completed |
NCT04277585 -
Improving Access to Early Psychosis Coordinated Specialty Care
|
N/A | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Not yet recruiting |
NCT05558332 -
Youth Nominated Support Team
|
N/A | |
Not yet recruiting |
NCT05358457 -
Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Completed |
NCT02895269 -
COllaborative Shared Care to IMprove Psychosis Outcome
|
N/A | |
Recruiting |
NCT02622048 -
Understanding and Helping Families: Parents With Psychosis
|
N/A | |
Completed |
NCT02733575 -
Compassion Focused Therapy for Distressing Experiences
|
N/A | |
Completed |
NCT02653729 -
Cbt for Psychosis and Affect on Psychosis Symptoms
|
Phase 2 | |
Completed |
NCT02531243 -
Computer-Aided Learning for Managing Stress
|
N/A | |
Not yet recruiting |
NCT02244970 -
Mindfulness RCT for Early Psychosis
|
N/A | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Recruiting |
NCT00722163 -
A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis
|
Phase 0 |